Navigation Links
Analysis of ()-11-Nor-9-Carboxy-Delta-9-THC in Urine by Negative Ion Electrospray LC/MS/MS

J. Beck and C. Schmidt, Varian, Inc.

Introduction

Marijuana is one of the most commonly used illegal recreational drugs in the United States. The compound that gives the high from smoking marijuana is tetrahydrocannabinol or THC. Toxicology, forensic, and clinical labs are often asked to analyze urine samples for the presence of one of the metabolites of THC, most frequently the carboxy form.

Traditionally, samples are screened for THC metabolites by immunoassay and confirmed using GC/MS. GC/MS, while the current standard for THC metabolite testing, requires time consuming sample derivatization prior to analysis. LC/MS provides the same specificity and sensitivity without the need for a derivatization process.

A simple, high throughput LC/MS/MS method is described here for the detection and quantitation of ()-11-nor-9-carboxydelta- 9-THC in urine.

Instrumentation

Varian ProStar 410 AutoSampler

Varian ProStar 210 Solvent Delivery Modules

Varian 1200L LC/MS/MS equipped with ESI source

Materials and Reagents

Standard solution: 0.1 mg/mL ()-11-Nor-9-Carboxy-Delta- 9-THC (Catalog No. T-006), from Cerilliant Corp., Texas, USA.

Internal standard (IS) solution: 500 ng/mL ()-11-Nor-9- Carboxy-Delta-9-THC-d9 in methanol, a gift from Norchem Drug Testing, Flagstaff, AZ.

Test samples: samples containing various amounts of ()-11- Nor-9-Carboxy-Delta-9-THC, also gifts from Norchem Drug Testing, Flagstaff, AZ.

All other chemicals are reagent grade or HPLC grade.

Sample Preparation

Serial dilutions of the standard solution of carboxy-THC (THCC) were prepared in deionized water. The concentrations of the samples ranged from 1 ng/mL (1 ppb) to 1000 ng/mL. A 50 μL
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Epitope-Tagging Vectors for Functional Analysis in Yeast
3. Map and Link Human Genetic Disorders with SSLP Analysis
4. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
5. Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf cMaster RTplusPCR System
6. Structural Analysis of Glycosylated Peptides in Complex Mixtures with Ion Trap MSn
7. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
8. Increased Sensitivity in Microarray Analysis
9. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
10. Agilent 2100 Bioanalyzer Automated Analysis System
11. Analysis of Microarray Data
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Analysis Nor Carboxy Delta THC Urine Negative Ion Electrospray

(Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... equipment, to creating professional commercial video content, to analysis of athletic performance. Producing ... events that go by too quickly to process with the naked eye. ...
(Date:9/1/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... Global Investment Conference sponsored by H.C. Wainwright ... St. Regis Hotel in New York, NY ... Chief Executive Officer, will provide an overview of the ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... Amarin Corporation plc,(NASDAQ: AMRN ) today announced ... to commence a Phase IIa trial in Age,Associated Memory ... IIa trial will be a randomized, double-blind,placebo-controlled study. The ... randomized to receive 1, 2 or 4 grams of ...
... Caliper Life,Sciences, Inc. (Nasdaq: CALP ) President ... 26th Annual Healthcare Conference in San Francisco,California, today, ... Mr.,Hrusovsky will discuss Caliper,s outlook for 2008, and ... 2007., Based on preliminary, unaudited financial data ...
... Hagens Berman Sobol Shapiro LLP,( http://www.hbsslaw.com/cellcyte.htm ) ... of CellCyte (OTC Bulletin Board: CCYG) for ... comes after CellCyte,s shares plunged 55 percent,after ... CEO Gary,Reys, educational and professional credentials., ...
Cached Biology Technology:Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 2Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 3Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 4Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today 2Hagens Berman Sobol Shapiro Investigating CellCyte 2
(Date:9/1/2015)... 1, 2015  Automation and pre-processing are reducing ... screening. This is the first step toward a ... become unintrusive. An assortment of portal scanners, biometric ... investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( http://www.frost.com/nf2b ...
(Date:8/26/2015)... -- The report "Multi-Factor Authentication (MFA) Market by ... & Immigration, Government, Banking, Defense, Commercial Security, Consumer Electronics, ... by MarketsandMarkets, Multi-Factor Authentication Market is expected to reach ... of 17.7% between 2015 and 2020. ... through 169 P ages and in-depth ...
(Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... PITTSBURGHCarnegie Mellon University,s Philip R. LeDuc will join more ... at the National Academies Keck Futures Initiative on Complexity ... Invited participants will discuss the topic of complexity ... systems and achieving a sustainable future. , "This ...
... love sending and receiving text messages through their cell phones ... But now a new study from the University of North ... to reduce children,s chances of becoming overweight or obese later ... behaviors now. Recent studies show that approximately 19 ...
... More than 4,000 health professionals are expected to attend ... to be held from December 3 7, 2008 ... available on the IOF website at www.iofbonehealth.org ... honoured to announce that HRH Princess Mahajakri Sirindhorn of ...
Cached Biology News:Carnegie Mellon's Philip LeDuc participates in think tank forums 2UNC study: Text messaging may help children fight off obesity 2UNC study: Text messaging may help children fight off obesity 3Less than one month to opening of world’s largest global congress on osteoporosis 2
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Lipofectin Reagent is the reagent of choice for some cell lines; cells of endothelial derivation transfect well with Lipofectin Reagent....
Request Info...
... peptide derived from the internal region of ... Specific for the internal region of the ... the target band at ~590 kDa. ... media from primary tracheobranchial epithelial cultures and ...
Biology Products: